The US Food and Drug Administration released their findings on the Pfizer/BioNTech Covid-19 vaccine data and said they complied with the guidelines in place for emergency authorization. Pfizer/BioNTech said their vaccine was 95% effective and had no adverse side effects, while applying for emergency authorization in the US. After the FDA report, the vaccine’s authorization is imminent.